The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

May 31, 2026

Conditions
Diabetes Mellitus
Interventions
DEVICE

Continuous Glucose Monitor

Participants will enroll in a series of remote educational visits conducted by CDCES to assess readiness and barriers to CGM initiation and utilization, with the goal to sustain use of CGM Technology over time in older populations on complex insulin regimen.

Trial Locations (2)

13210

SUNY Upstate Medical University, Syracuse

02215

Joslin Diabetes Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

State University of New York - Upstate Medical University

OTHER

collaborator

Cecilia Health

UNKNOWN

lead

Joslin Diabetes Center

OTHER

NCT05337826 - The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes | Biotech Hunter | Biotech Hunter